tiprankstipranks

Yong-Jun Huh Insider Profile

4 Followers
Yong-Jun Huh, Director at Artiva Biotherapeutics, Inc., holds 4.57M shares in Artiva Biotherapeutics, Inc. (Ticker: ARTV).
tipranks
Yong-Jun Huh

Yong-Jun Huh
Artiva Biotherapeutics, Inc. (ARTV)
Director

Not Ranked
Yong-Jun Huh has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$51M
100.00%
A breakdown of Yong-Jun Huh's holdings

Insider Roles

Artiva Biotherapeutics, Inc.
(ARTV)
Director
Roles that Yong-Jun Huh holds in companies

Most Profitable Insider Trade

Stock:
Artiva Biotherapeutics, Inc.
(ARTV)
Rating:Informative Buy
Date:Jul 22, 2024 - Today
Return:-5.60%
The most profitable trade made by Yong-Jun Huh

Yong-Jun Huh's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Artiva Biotherapeutics, Inc.
Jul 22, 2024
Director
Uninformative Buy
5.61M
$50.74M
Success Rate for
ARTV
0 out of 1 profitable transactions on
ARTV
0%
Average Return for
ARTV
Average return per transaction on
ARTV
-5.60%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jul 22, 2024
Uninformative Buy
$5.61M
-
$0.00
Jul 22, 2024
Informative Buy
$25.00M
-
$12.00
-5.60%
List of latest transactions for each holding click on a transaction to see Yong-Jun Huh's performance on stock

Yong-Jun Huh insider profile FAQ

What is the percentage of profitable transactions made by Yong-Jun Huh?
The percentage of profitable transactions made by Yong-Jun Huh is ―.
    What is the average return per transaction made by Yong-Jun Huh?
    The average return per transaction made by Yong-Jun Huh is ―.
      What stocks does Yong-Jun Huh hold?
      Yong-Jun Huh holds: ARTV stocks.
        What was Yong-Jun Huh’s latest transaction?
        Yong-Jun Huh latest transaction was an Uninformative Buy of $5.61M.
          What was Yong-Jun Huh's most profitable transaction?
          Yong-Jun Huh’s most profitable transaction was an Informative Buy of ARTV stock on July 22, 2024. The return on the trade was -5.60%.
            What is Yong-Jun Huh's role in Artiva Biotherapeutics, Inc.?
            Yong-Jun Huh's role in Artiva Biotherapeutics, Inc. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.